26,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
13 °P sammeln
  • Broschiertes Buch

Cancer is the second most common cause of mortality of human being. Research is going on all over the world to develop treatment modalities, including chemotherapy for better management of this deadly disease. Drugs lead compounds of natural origin are the potential candidate for the development of functionally active chemotherapeutic agents. Eucalyptus is a diverse genus (more than 700 species) of flowering tree distributed worldwide predominantly in tropics and subtropics. Bio-active principles obtained from Eucalyptus have wide range of pharmacological potentials as well as applications.…mehr

Produktbeschreibung
Cancer is the second most common cause of mortality of human being. Research is going on all over the world to develop treatment modalities, including chemotherapy for better management of this deadly disease. Drugs lead compounds of natural origin are the potential candidate for the development of functionally active chemotherapeutic agents. Eucalyptus is a diverse genus (more than 700 species) of flowering tree distributed worldwide predominantly in tropics and subtropics. Bio-active principles obtained from Eucalyptus have wide range of pharmacological potentials as well as applications. This work was designed to investigate the anticancer property of E. camaldulensis in animal model. Compounds and extracts from this plant exhibited strong inhibition of cancer cells growth with minimal host toxicity. Apoptosis of cancer cells was triggered with the treatment of this plant ingredient. Development of drugs exploiting Eucalyptus may unveil a new hope for cancer treatment in future
Autorenporträt
Md Farhadul Islam graduated from the Dept. of Biochemistry and Molecular Biology, Rajshahi University, Bangladesh. He is working as a full-time academic in the same Dept. since-2010. Cancer biology and cancer drugs development is the field of his works. He has published a good numbers of articles on cancer research in the international journals.